Literature DB >> 19828182

Successful treatment of intraorbital lymphangioma with tissue fibrin glue.

Aiko Hayasaki1, Hideo Nakamura, Tadashi Hamasaki, Keishi Makino, Shigetoshi Yano, Motohiro Morioka, Jun-ichi Kuratsu.   

Abstract

BACKGROUND: Although surgical resection is the first treatment choice in patients with cystic lymphangioma, the complete resection of orbital lymphangioma is often difficult. After partial resection of the cyst wall, some cystic lymphangiomas recur. The injection of tissue fibrin glue may prevent the recurrence of orbital lymphangioma. CASE DESCRIPTION: We present a 2-year-old girl with left progressive exophthalmos. Magnetic resonance imaging revealed a cystic mass lesion behind the left eyeball. At the first operation, the cyst wall was partially resected, and all cyst fluid was totally removed by suction. One week after the first operation, the cyst showed regrowth. At a second procedure, we injected tissue fibrin glue into the cyst. The cyst was completely sealed, and there was no recurrence.
CONCLUSION: Tissue fibrin glue is adhesive and hemostatic and highly useful in the treatment of orbital cystic lymphangioma. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19828182     DOI: 10.1016/j.surneu.2009.04.013

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  3 in total

1.  Surgical Reconstruction of Ocular Surface Tumors Using Fibrin Sealant Tissue Adhesive.

Authors:  Aline Roseane Queiroz de Paiva; Larissa Abreu de Azevedo Fraga; Virgínia Laura Lucas Torres
Journal:  Ocul Oncol Pathol       Date:  2016-03-15

2.  Interventions for orbital lymphangioma.

Authors:  Sheel R Patel; Jamie B Rosenberg; Anne Barmettler
Journal:  Cochrane Database Syst Rev       Date:  2019-05-15

3.  Intraoperative use of indocyanine green and trypan blue mixed with fibrin glue in the excision of periocular cystic lesions.

Authors:  Nariman S Boyle; Eli L Chang
Journal:  Am J Ophthalmol Case Rep       Date:  2020-11-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.